Fortis Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,011
| Closed | -$641K | – | 274 |
|
|
2025
Q1 | $641K | Sell |
1,011
-660
| -39% | -$419K | 0.13% | 134 |
|
|
2024
Q4 | $1.98M | Buy |
1,671
+132
| +9% | +$156K | 0.68% | 22 |
|
|
2024
Q3 | $1.62M | Buy |
1,539
+32
| +2% | +$33.6K | 0.54% | 32 |
|
|
2024
Q2 | $1.58M | Buy |
1,507
+457
| +44% | +$480K | 0.57% | 27 |
|
|
2024
Q1 | $1.01M | Buy |
1,050
+721
| +219% | +$694K | 0.43% | 41 |
|
|
2023
Q4 | $289K | Sell |
329
-16
| -5% | -$14.1K | 0.15% | 91 |
|
|
2023
Q3 | $284K | Sell |
345
-28
| -8% | -$23K | 0.18% | 79 |
|
|
2023
Q2 | $268K | Sell |
373
-104
| -22% | -$74.7K | 0.16% | 88 |
|
|
2023
Q1 | $392K | Sell |
477
-141
| -23% | -$116K | 0.21% | 66 |
|
|
2022
Q4 | $446K | Buy |
+618
| New | +$446K | 0.27% | 56 |
|